[Source: Proceedings of the National Academy of Sciences of the United States of America, full page: (LINK). Abstract, edited.]
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
...
17 results in 0.0429 seconds.
-
Giuseppe started a topic Proc Natl Acad Sci USA. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccinationin VaccinesProc Natl Acad Sci USA. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
-
Giuseppe started a topic PLoS ONE. Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canadain VaccinesPLoS ONE. Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canada
[Source: PLoS ONE, full text: (LINK). Abstract, edited.]
Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canada...
by David N. Fisman, Ashleigh R. Tuite -
Giuseppe started a topic Proc Natl Acad Sci USA. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59in VaccinesProc Natl Acad Sci USA. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59 (PNAS, abstract, edited)
[Source: Proc Natl Acad Sci USA, full text: <cite cite="htt... -
Giuseppe started a topic Vaccine. Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.in VaccinesVaccine. Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.
[Source: US National Library of Medicine (LINK). Edited.]
Vaccine. 2010 Apr 28. [Epub ahead of print]
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines... -
Giuseppe started a topic Vaccine. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.in VaccinesVaccine. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
[Source: US National Library of Medicine (LINK). Edited.]
Vaccine. 2010 Apr 27. [Epub ahead of print]
Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary... -
Giuseppe started a topic N Engl J Med. Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccinein VaccinesN Engl J Med. Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine (N Engl J Med., abstract, edited)
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine...
Tristan W. Clark, M.R.C.P., Manish Pareek, M.R.C.P., Katja -
Giuseppe started a topic Vaccine. Exposure to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective analysis.in VaccinesVaccine. Exposure to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective analysis.
Vaccine. 2009 Dec 4. [Epub ahead of print]
Exposure to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective analysis.
Tsai T, Kyaw MH, Novicki D, Nacci P, Rai S, Clemens R. - Novartis Vaccines and Diagnostics,... -
Giuseppe started a topic Vaccine. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.in VaccinesVaccine. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
Vaccine. 2009 Oct 23;27(45):6291-5.
MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
Vesikari T, Groth N, Karvonen A, Borkowski A, Pellegrini... -
Giuseppe started a topic Euro Surveill. Pandemic influenza A(H1N1) 2009 vaccines in the European Unionin VaccinesEuro Surveill. Pandemic influenza A(H1N1) 2009 vaccines in the European Union
Euro Surveill. Pandemic influenza A(H1N1) 2009 vaccines in the European Union (edited)
Eurosurveillance, Volume 14, Issue 41, 15 October 2009...
Perspectives
Pandemic influenza A(H1N1) 2009 vaccines in the European Uni -
Giuseppe started a topic Vaccine. MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database.in VaccinesVaccine. MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database.
Vaccine. 2009 Sep 11. [Epub ahead of print]
MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database.
Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. - Global... -
Giuseppe started a topic N Engl J Med. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine ? Preliminary Reportin VaccinesN Engl J Med. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine ? Preliminary Report
Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine ? Preliminary Report (NEJM, abstract, edited)
[Source Full Free Document: LINK. EDITED.]
Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine... -
Vaccine. Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses.
Vaccine. 2009 Aug 6. [Epub ahead of print]
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses.
Alberini I, Del Tordello E, Fasolo A, Temperton N, Galli G, Gentile... -
Regulators face tough flu-jab choices : Nature News
Regulators face tough flu-jab choices : Nature News
Published online 21 July 2009 | Nature | doi:10.1038/460446a...
News
Regulators face tough flu-jab choices
Rich countries' pandemic strategies may cause vaccine -
Germany's countdown for swine flu vaccination
Media-report SPIEGEL ONLINE:
US administration will start a vaccination campaign for swine flu in October. The German Government also is looking at mass vaccination. The population groups to be vaccinated first ought to be defined the next week,... -
Giuseppe started a topic Proc Natl Acad Sci USA. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.in VaccinesProc Natl Acad Sci USA. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7. Epub 2009 Apr 27.
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
Galli...